NYCSHP’s August CE dinner program took place at Club A Steakhouse in Midtown East, New York. Dr. Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology) from Bristol-Meyers Squibb presented an overview on the, “Treatment of DVT and PE and Reduction of Recurrent DVT and PE Following Initial Therapy.” She discussed major findings from the Amplify-EXT clinical trial including data on extended anticoagulation with apixaban (Eliquis).
Following Dr. Spinler’s presentation, President, Dr. Karen Berger made a few announcements about the following events: September 7th NYCSHP Board of Directors Meeting, September 12th New Practitioners Networking Dinner, September 14th Networking event, and September 21st Industry Relations CE Meeting. In addition, Dr. Andrew Kaplan provided members with policy updates regarding the technician and CDTM bills, and how members can get involved with the New York City Grassroots Lobbying Committee.
Following NYCSHP announcements, Dr. Berger welcomed our speaker for the CE Program, Dr. Amanda Cantin, PharmD, BCCCP, Assistant Professor from Touro College of Pharmacy. Dr. Cantin presented on, “Sepsis: The Silent Killer.” Dr. Cantin pointed out major key points from the 2016 Surviving Sepsis Campaign (SSC) guidelines and the role of novel therapies in sepsis and septic shock. Much thanks to Bristol-Meyers Squibb for their support in sponsoring this eventful night.
Written by Gretchen Marcelino
Edited by Karen Berger and Jamie Chin
Photos by Andrew Kaplan and Zane Last